Masimo (NASDAQ:MASI) Earns "Sell (D)" Rating from Weiss Ratings

Key Points

• Masimo's stock is rated "Sell (D)" by Weiss Ratings, while Piper Sandler raised its target price from $200 to $210 with an "overweight" rating.
• The company's quarterly earnings report showed $1.33 EPS, exceeding analysts' estimates, with revenue up 7.7% year-over-year.
• Director William R. Jellison increased his stake by acquiring 3,000 shares at an average price of $145.98, raising his ownership by 167.6%.

Masimo (NASDAQ:MASI - Get Free Report)'s stock had its "sell (d)" rating reissued by investment analysts at Weiss Ratings in a report issued on Wednesday,Weiss Ratings reports.

A number of other equities research analysts have also recently issued reports on MASI. Piper Sandler raised their target price on Masimo from $200.00 to $210.00 and gave the company an "overweight" rating in a research note on Wednesday, August 6th. Zacks Research upgraded Masimo from a "hold" rating to a "strong-buy" rating in a research note on Wednesday, September 3rd. Wall Street Zen cut Masimo from a "buy" rating to a "hold" rating in a research note on Monday. Finally, BTIG Research reiterated a "buy" rating and issued a $198.00 target price on shares of Masimo in a research note on Thursday, September 11th. One research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $194.60.

Masimo Stock Performance

Masimo stock opened at $153.72 on Wednesday. The company has a market cap of $8.35 billion, a PE ratio of -18.04 and a beta of 1.28. The company has a fifty day moving average price of $146.28 and a two-hundred day moving average price of $155.61. The company has a debt-to-equity ratio of 0.57, a current ratio of 2.14 and a quick ratio of 1.61. Masimo has a 12 month low of $133.70 and a 12 month high of $194.88.

Masimo (NASDAQ:MASI - Get Free Report) last released its quarterly earnings data on Tuesday, August 5th. The medical equipment provider reported $1.33 EPS for the quarter, topping analysts' consensus estimates of $1.22 by $0.11. The firm had revenue of $370.90 million during the quarter, compared to the consensus estimate of $368.65 million. Masimo had a negative net margin of 24.85% and a positive return on equity of 26.54%. The firm's revenue was up 7.7% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.86 earnings per share. Research analysts expect that Masimo will post 4.1 earnings per share for the current year.

Insider Buying and Selling at Masimo

In related news, Director William R. Jellison acquired 3,000 shares of the business's stock in a transaction that occurred on Monday, August 11th. The shares were acquired at an average cost of $145.98 per share, for a total transaction of $437,940.00. Following the completion of the purchase, the director directly owned 4,790 shares in the company, valued at $699,244.20. This trade represents a 167.60% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is accessible through the SEC website. 9.70% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Masimo

Several hedge funds and other institutional investors have recently bought and sold shares of the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in Masimo by 0.6% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 11,371 shares of the medical equipment provider's stock worth $1,894,000 after acquiring an additional 66 shares in the last quarter. Assetmark Inc. raised its position in Masimo by 5.0% in the second quarter. Assetmark Inc. now owns 1,539 shares of the medical equipment provider's stock worth $259,000 after acquiring an additional 73 shares in the last quarter. Xponance Inc. raised its position in Masimo by 1.1% in the first quarter. Xponance Inc. now owns 7,101 shares of the medical equipment provider's stock worth $1,183,000 after acquiring an additional 76 shares in the last quarter. Deutsche Bank AG raised its position in Masimo by 1.5% in the first quarter. Deutsche Bank AG now owns 6,309 shares of the medical equipment provider's stock worth $1,051,000 after acquiring an additional 92 shares in the last quarter. Finally, State of Michigan Retirement System raised its position in Masimo by 1.0% in the first quarter. State of Michigan Retirement System now owns 10,596 shares of the medical equipment provider's stock worth $1,765,000 after acquiring an additional 100 shares in the last quarter. 85.96% of the stock is currently owned by institutional investors.

Masimo Company Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.